Cefacetrile
From Wikipedia, the free encyclopedia
Cefacetrile
|
|
Systematic (IUPAC) name | |
(6R,7R)-3-(acetyloxymethyl)-7-[(2-cyanoacetyl)amino]- 8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid |
|
Identifiers | |
CAS number | 10206-21-0 |
ATC code | J01DB10 |
PubChem | 91562 |
Chemical data | |
Formula | C13H13N3O6S |
Mol. weight | 339.325 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | 23 to 38% |
Metabolism | ? |
Half life | 1.2 hours |
Excretion | Renal (72%) |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | Intravenous, intramuscular |
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in Gram-positive and Gram-negative bacterial infections. It is a bacteriostatic antibiotic. Cefacetrile is marketed under the tradenames Celospor®, Celtol®, and Cristacef®.
Cephalosporin Antibiotics (J01D) edit | ||
---|---|---|
First Generation: |
Cefacetrile, Cefadroxil, Cefalexin, Cefaloglycin, Cefalonium, Cefaloridine, Cefalotin, Cefapirin, Cefatrizine, Cefazaflur, Cefazedone, Cefazolin, Cefradine, Cefroxadine, Ceftezole |
|
Second Generation: |
Cefaclor, Cefamandole, Cefonicid, Ceforanide, Cefotiam, Cefprozil, Cefuroxime, Cefuzonam |
|
Third Generation: |
Cefcapene , Cefdaloxime, Cefdinir, Cefditoren, Cefetamet, Cefixime, Cefmenoxime, Cefodizime, Cefoperazone, Cefotaxime, Cefpimizole, Cefpiramide, Cefpodoxime, Cefsulodin, Ceftazidime, Cefteram, Ceftibuten, Ceftiofur, Ceftiolene, Ceftizoxime, Ceftriaxone, Latamoxef |
|
Fourth Generation: |
Cefclidine, Cefepime, Cefetecol, Cefluprenam, Cefoselis, Cefozopran, Cefpirome, Cefquinome |